Literature DB >> 21856262

Infections in the operated spine: update on risk management and therapeutic strategies.

J-Y Lazennec1, E Fourniols, T Lenoir, A Aubry, M-L Pissonnier, B Issartel, M-A Rousseau.   

Abstract

UNLABELLED: Among the possible risks of spine surgery, surgical site infection (SSI) is far from negligible. Incidence is higher than in other locomotor system procedures, with more severe local and general impact. Certain broad guidelines can be formulated. The risk of SSI should be taken into account in the choice of treatment options discussed with the patient. Antibiotic prophylaxis, surgical prevention of iatrogenic infection and an SSI surveillance protocol should be implemented. SSI should be suspected in case of any abnormality in postoperative course, and biological and imaging (MRI or CT) measures should be taken. Local sampling for bacteriological identification is mandatory. Treatment strategy should ideally be discussed in a multidisciplinary coordination meeting, and adapted in the light of local bacterial ecology and resistance data. The information provided to the patient should be transparent and adapted to the patient's individual context. LEVEL OF EVIDENCE: Level V.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21856262     DOI: 10.1016/j.otsr.2011.07.002

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  21 in total

1.  The follow-up of patients with postoperative infection of the spine.

Authors:  C Barrey; O Launay; E Freitas; F Michel; F Laurent; C Chidiac; G Perrin; T Ferry
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-28

2.  Management of postoperative spinal infections.

Authors:  Vishal Hegde; Dennis S Meredith; Christopher K Kepler; Russel C Huang
Journal:  World J Orthop       Date:  2012-11-18

3.  Variables associated with remission in spinal surgical site infections.

Authors:  Julien Billières; Ilker Uçkay; Antonio Faundez; Jonathan Douissard; Paulina Kuczma; Domizio Suvà; Mathieu Zingg; Pierre Hoffmeyer; Dennis E Dominguez; Guillaume Racloz
Journal:  J Spine Surg       Date:  2016-06

4.  Use of PET/CT in the early diagnosis of implant related wound infection and avoidance of wound debridement.

Authors:  Yue Wang; Jason Pui-Yin Cheung; Kenneth Man-Chee Cheung
Journal:  Eur Spine J       Date:  2015-05-31       Impact factor: 3.134

5.  Epidemiology of Surgical Site Infections and Non-Surgical Infections in Neurosurgical Polish Patients-Substantial Changes in 2003⁻2017.

Authors:  Małgorzata Kołpa; Marta Wałaszek; Anna Różańska; Zdzisław Wolak; Jadwiga Wójkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2019-03-13       Impact factor: 3.390

Review 6.  Immobilized antibiotics to prevent orthopaedic implant infections.

Authors:  Noreen J Hickok; Irving M Shapiro
Journal:  Adv Drug Deliv Rev       Date:  2012-04-04       Impact factor: 15.470

7.  Reducing surgical site infection in spinal surgery with betadine irrigation and intrawound vancomycin powder.

Authors:  Marko Tomov; Lance Mitsunaga; Blythe Durbin-Johnson; Deepak Nallur; Rolando Roberto
Journal:  Spine (Phila Pa 1976)       Date:  2015-04-01       Impact factor: 3.468

8.  Surgical Site Infections after Spinal Surgery in a Tropical Area: A Prospective Monocentric Observational Study.

Authors:  Mathieu Severyns; François-Xavier Hostalrich; Laure Flurin; Tanguy Vendeuvre; Arnaud Germaneau; Jean-Marie Turmel; André Cabié; Abdelkrim Benchikh El-Fegoun
Journal:  Am J Trop Med Hyg       Date:  2022-06-27       Impact factor: 3.707

Review 9.  [Infections after reconstructive spinal interventions : How do I deal with them?]

Authors:  Burkhard Lehner; Michael Akbar; Nicholas A Beckmann
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

Review 10.  Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis.

Authors:  Nathan Evaniew; Moin Khan; Brian Drew; Devin Peterson; Mohit Bhandari; Michelle Ghert
Journal:  Eur Spine J       Date:  2014-05-18       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.